Naloxegol Drug Utilization Post Authorisation Safety Study

NCT02813148 · clinicaltrials.gov ↗

COMPLETED

Status

17254

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Induced Constipation

Interventions

DRUG: Naloxegol

Sponsor

Kyowa Kirin Pharmaceutical Development Ltd